Cross-coupling of unactivated secondary boronic acids

US10072028B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10072028-B2
Application numberUS-201415034102-A
CountryUS
Kind codeB2
Filing dateNov 3, 2014
Priority dateNov 3, 2013
Publication dateSep 11, 2018
Grant dateSep 11, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are methods for site- and stereo-retentive cross-couplings with unactivated secondary boronic acids, which methods are particularly useful in building block-based approach for small molecule synthesis. Also provided is a method of forming an air-stable chiral secondary boronic acid.

First claim

Opening claim text (preview).

We claim: 1. A method of forming a chiral non-racemic secondary boronic acid, comprising: combining a chiral compound of formula (I) wherein, independently for each occurrence, R 1 and R 2 are selected from the group consisting of substituted C 1 -C 6 alkyl and unsubstituted C 1 -C 6 alkyl; a chiral iminodiacetic acid, wherein the chiral iminodiacetic acid is not a racemic mixture; pyridinium p-toluenesulfonate (PPTS); and a polar aprotic solvent, thereby forming a mixture of chiral boronates; resolving the mixture of chiral boronates into individual diastereomers; and hydrolyzing an individual diastereomer, thereby forming the chiral non-racemic secondary boronic acid. 2. The method of claim 1 , wherein the hydrolyzing is with aqueous hydroxide. 3. The method of claim 1 , wherein the chiral iminodiacetic acid has an enantiomeric excess of at least 80 percent. 4. The method of claim 1 , wherein the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA). 5. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 80 percent. 6. The method of claim 1 , wherein the resolving is by crystallization. 7. The method of claim 1 , wherein the resolving is by chromatography. 8. The method of claim 1 , wherein the hydrolyzing is with aqueous NaOH. 9. The method of claim 1 , wherein the chiral iminodiacetic acid has an enantiomeric excess of at least 90 percent. 10. The method of claim 1 , wherein the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent. 11. The method of claim 1 , wherein the polar aprotic solvent is CH 3 CN. 12. The method of claim 1 , wherein the compound of formula (I) is a racemic mixture. 13. The method of claim 1 , wherein the compound of formula (I) is not a racemic mixture. 14. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 90 percent. 15. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent. 16. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 80 percent; and the chiral iminodiacetic acid has an enantiomeric excess of at least 80 percent. 17. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 90 percent; and the chiral iminodiacetic acid has an enantiomeric excess of at least 90 percent. 18. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; and the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent. 19. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 80 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 80 percent; and the compound of formula (I) is a racemic mixture. 20. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 90 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 90 percent; and the compound of formula (I) is a racemic mixture. 21. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; and the compound of formula (I) is a racemic mixture. 22. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; and the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA). 23. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA); and the compound of formula (I) is a racemic mixture. 24. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA); the compound of formula (I) is a racemic mixture; and the hydrolyzing is with aqueous hydroxide. 25. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA); the compound of formula (I) is a racemic mixture; and the hydrolyzing is with aqueous NaOH. 26. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA); the compound of formula (I) is a racemic mixture; the hydrolyzing is with aqueous NaOH; and the polar aprotic solvent is CH 3 CN.

Assignees

Inventors

Classifications

  • Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring · CPC title

  • Substitution · CPC title

  • by increase in the number of carbon atoms · CPC title

  • containing two rings · CPC title

  • C07F5/025Primary

    Boronic and borinic acid compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10072028B2 cover?
Provided are methods for site- and stereo-retentive cross-couplings with unactivated secondary boronic acids, which methods are particularly useful in building block-based approach for small molecule synthesis. Also provided is a method of forming an air-stable chiral secondary boronic acid.
Who is the assignee on this patent?
Univ Illinois
What technology area does this patent fall under?
Primary CPC classification C07F5/025. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).